CAS公司推出新型生命体征监测仪

一种新型生命体征监测仪综合了二氧化碳描记、脉搏血氧仪以及血压监测等方面的进展。这种仪器已经获得了美国食品药品管理局的批准。

这种CAS 750C是由CAS医疗公司研制开发的，配备了以色列Oridion 公司的Microstream 二氧化碳描记、美国Masimo公司的脉搏血氧仪以及CAS MAXNIBP血压监测技术。

这种重量轻、便携式监测仪具有多种用途，从急症护理到程序化镇静治疗。Microstream capnography和采集样本辅助功能在临床上十分有用，可以是峰谷CO2的监测效率更高，也更加有效。CAS公司声称。联合应用Maximo SET脉搏血氧仪技术，这种监测仪为辅助呼吸和氧疗制定了新的标准。这家公司的产品在全球范围内得到了广泛应用。

CAS公司总裁兼首席执行官Louis P. Scheps评论说：“我们十分高兴的宣布，这种750C产品加入到我们公司的生命体征监测产品生产线。使用终末峰谷CO2检测技术，我们进一步扩大了检测能力，为临床医生提供更多的患者生命体征信息。”
 
Novel Vital Signs Monitor
 
A new vital signs monitor incorporates advances in capnography, pulse oximetry, and blood pressure monitoring. The monitor has been cleared by the U.S. Food and Drug Administration (FDA).

The CAS 750C, developed by CAS Medical Systems, Inc. (Branford, CT, USA), incorporates the Microstream capnography of Oridion Systems, Ltd. (Jerusalem, Israel), the pulse oximetry of Masimo Corp. (Irvine, CA, USA), and the CAS MAXNIBP blood-pressure monitoring technology.

The lightweight, portable monitor is designed for a variety of applications, ranging from emergency care to procedural sedation. The Microstream capnography and sampling accessories provide clinical advantages that make tidal CO2 monitoring more efficient and effective. Combined with the Maximo SET pulse oximetry technology, the monitor sets a new standard in monitoring ventilation and oxygenation, states CAS. The company’s products are used by doctors worldwide.

“We are very pleased to announce the addition of the 750C to our vital signs monitoring product line,” commented Louis P. Scheps, president and CEO of CAS Medical Systems, Inc. “With end tidal CO2 technology, we have further expanded our measurement capabilities and the breadth of information we can provide to clinicians regarding their patients’ vital statistics.